^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

PM3023

i
Other names: PM3023, CLDN18.2 CAB-T
Associations
Trials
Company:
Biotheus
Drug class:
CLDN18.2 inhibitor, T-cell stimulant
Related drugs:
Associations
Trials